Profilo
Wu-Sung Ki è amministratore delegato e direttore di Celltrion, Inc. Nella sua carriera passata il signor Ki è stato vicepresidente di Celltrion Skincure Co.
Posizioni attive di Wu-Sung Ki
| Società | Posizione | Inizio |
|---|---|---|
| CELLTRION, INC. | Amministratore Delegato | 20/03/2015 |
Precedenti posizioni note di Wu-Sung Ki
| Società | Posizione | Fine |
|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Amministratore Delegato | - |
Celltrion Skincure Co., Ltd.
 Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Direttore/Membro del Consiglio | 15/10/2014 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CELLTRION, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Celltrion Skincure Co., Ltd.
Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Healthcare Co., Ltd.
 Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
- Borsa valori
- Insiders
- Wu-Sung Ki
